NASDAQ: FLSCFrazier Life Sciences Acquisition Corp II Stock
$10.35-0.14 (-1.33%)
Updated Oct 16, 2026
FLSC Price
$10.35
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$10.18
52 Week High
$10.59
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
4.47
Operating Cash Flow
N/A
Beta
2.36
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
FLSC Overview
Blank-check company formed for the purpose of effecting a merger, acquisition, or similar business combination.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FLSC's potential to beat the market
- FLSC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
FLSC
RankedUnranked of 17
RankedUnranked of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.30 | C | |
| $10.07 | C | |
| $10.64 | C |
Be the first to know about important FLSC news, forecast changes, insider trades & much more!
FLSC News
Overview
Due Diligence Score
–
Industry Average (8)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FLSC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FLSC's short-term liabilities ($72.13k) exceed its short-term assets ($26.48k)
Short-term Liabilities Financials
FLSC's short-term assets ($26.48k) exceed its long-term liabilities ($10.50k)
Long-term Liabilities Financials
FLSC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
There are 30 more FLSC due diligence checks available for Premium users.
Valuation
FLSC's financial health
Profit margin
Revenue
$0.0
Net Income
-$6.5k
Profit Margin
0%
Assets to liabilities
Assets
$101.1k
Liabilities
$82.6k
Debt to equity
4.47
FLSC's short-term liabilities ($72.13k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FLSC's short-term assets ($26.48k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FLSC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$33.0k
Investing
$0.0
Financing
$33.0k
Frazier Life Sciences Acquisition II Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.